| Citation: |
CHEN Yanrong, LIU Yan, WANG Shan, ZHANG Jing. Expression characteristics and detection value of histamine, soluble myeloid cell trigger receptor-1, microribonuclease-145 and high-sensitivity C-reactive protein in patients with chronic obstructive pulmonary disease and coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 1-5. DOI: 10.7619/jcmp.20223161
|
To investigate the expression characteristics and detection value of histamine (HA), soluble myeloid cell trigger receptor-1 (sTREM-1), microribonuclease-145 (miR-145) and hypersensitive C-reactive protein (hs-CRP) in patients with chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD).
A total of 107 healthy people with COPD and CHD were selected as study group, and 107 healthy people with physical examinations in the same period were selected as control group. The blood samples of the subjects were taken to measure the levels of miR-145, HA, sTREM-1 and hs-CRP. The levels of HA, sTREM-1, miR-145 and hs-CRP in the study group and the control group were compared, and their levels in different disease severity and different New York Heart Association(NYHA) grades were compared, and the correlations of the level of each indicator with the disease severity and NYHA grades were observed.
The levels of HA, sTREM-1 and hs-CRP in the study group were higher than those in the control group, and the level of miR-145 was lower than those in the control group (P < 0.05). The levels of HA, sTREM-1, miR-145 and hs-CRP in patients with different degrees of COPD showed significant difference, and with increase of the severity of the disease, HA, sTREM-1 and hs-CRP continued to increase, while miR-145 continued to decrease (P < 0.05). The levels of HA, sTREM-1, miR-145 and hs-CRP in different NYHA grades showed significant differences, and with the increase of NYHA grades, HA, sTREM-1 and hs-CRP continued to increase, while miR-145 continued to decrease (P < 0.05). HA, sTREM-1, hs-CRP were positively correlated with the severity of COPD and NYHA grade, while miR-145 was negatively correlated with the severity of COPD and NYHA grade (P < 0.05).
The expression of HA, sTREM-1, miR-145 and hs-CRP are abnormal in patients with COPD and CHD, which is closely related to the severity of COPD and NYHA grade.
| [1] |
何玉, 秦明照. 慢性阻塞性肺疾病对冠状动脉粥样硬化性心脏病患者的影响[J]. 中国心血管杂志, 2019, 24(4): 324-327. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201904008.htm
|
| [2] |
ANDRÉ S, CONDE B, FRAGOSO E, et al. COPD and cardiovascμLar disease[J]. PμLmonology, 2019, 25(3): 168-176. doi: 10.1016/j.pulmoe.2018.09.006
|
| [3] |
WANG J J. Risk of coronary heart disease in people with chronic obstructive pμLmonary disease: a meta-analysis[J]. Int J Chron Obstruct PμLmon Dis, 2021, 16: 2939-2944. doi: 10.2147/COPD.S331505
|
| [4] |
刘琼, 余晖, 周慧良. 361例冠心病心绞痛患者急性心血管事件发生率及危险因素分析[J]. 心血管康复医学杂志, 2021, 30(1): 26-29. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGK202101010.htm
|
| [5] |
王澈, 杨宏辉, 杜秋波, 等. 老年冠心病合并慢性阻塞性肺疾病患者血清中P物质、组胺水平及临床意义[J]. 中国老年学杂志, 2021, 41(9): 1793-1796. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ202109001.htm
|
| [6] |
卢莎莎, 段勇波, 宋煜, 等. 血清IL-38、sTREM-1、IL-6水平与COPD病情变化的关系[J]. 医学临床研究, 2021, 38(6): 912-914. doi: 10.3969/j.issn.1671-7171.2021.06.031
|
| [7] |
KIM R Y, SUNKARA K P, BRACKE K R, et al. A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pμLmonary disease pathogenesis[J]. Sci Transl Med, 2021, 13(621): 7223. doi: 10.1126/scitranslmed.aav7223
|
| [8] |
赵盼盼, 侯梦一. MiR-145、miR-146a在慢性阻塞性肺疾病合并冠心病患者血清中的表达及临床意义[J]. 临床检验杂志, 2020, 38(12): 914-918. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJY202012008.htm
|
| [9] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202129002.htm
|
| [10] |
中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694. https://www.cnki.com.cn/Article/CJFDTOTAL-XXFZ201902001.htm
|
| [11] |
DAHER A, DREHER M. The bidirectional relationship between chronic obstructive pμLmonary disease and coronary artery disease[J]. Herz, 2020, 45(2): 110-117.
|
| [12] |
宋雨童, 谭菲, 颜明. 慢性阻塞性肺疾病患者合并冠心病的危险因素分析[J]. 中华老年多器官疾病杂志, 2021, 20(5): 359-363. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLQG202105010.htm
|
| [13] |
RAGHAVAN S, LEO M D. Histamine potentiates SARS-CoV-2 spike protein entry into endothelial cells[J]. Front Pharmacol, 2022, 13: 872736.
|
| [14] |
许莉莉, 朱宝玲, 杨向东. 组胺与固有免疫细胞分化在冠心病研究中的新认识[J]. 中国动脉硬化杂志, 2019, 27(5): 369-373. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201905002.htm
|
| [15] |
MOYA-GARCÍA A A, PINO-ÅNGELES A, SÁNCHEZ-JIMÉNEZ F, et al. Histamine, metabolic remodelling and angiogenesis: a systems level approach[J]. BiomolecμLes, 2021, 11(3): 415.
|
| [16] |
张海娜, 钱振萍, 丁锡富, 等. 慢性阻塞性肺疾病合并肺部真菌感染患者血浆(1-3)-β-D葡聚糖与sTREM-1的表达[J]. 中华医院感染学杂志, 2019, 29(22): 3401-3404. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201922009.htm
|
| [17] |
SHIBER S, KLIMINSKI V, ORVIN K, et al. Elevated plasma soluble triggering receptor expressed on myeloid cells-1 level in patients with acute coronary syndrome (ACS): a biomarker of disease severity and outcome[J]. Mediators Inflamm, 2021, 2021: 8872686.
|
| [18] |
周榕, 崔晓雪, 华正东, 等. 慢性阻塞性肺疾病合并冠心病患者sTREM-1及炎症状态与冠状动脉病变程度的相关性[J]. 中南医学科学杂志, 2021, 49(3): 331-334. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY202103018.htm
|
| [19] |
颜月, 李桃, 方蕾. MiR-144/451在呼吸系统疾病中的研究进展[J]. 医学综述, 2020, 26(11): 2117-2121, 2127. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202011007.htm
|
| [20] |
高健敏, 朱勇德, 符国平. 血浆miRNA-145、miRNA-183水平在慢性阻塞性肺疾病急性加重期诊断及预后评估中的应用[J]. 郑州大学学报: 医学版, 2022, 57(4): 491-495. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202204010.htm
|
| [21] |
蔡晓航. 冠心病患者血清miR-145、TREML4水平变化及临床意义[J]. 四川生理科学杂志, 2020, 42(1): 26-29. https://www.cnki.com.cn/Article/CJFDTOTAL-SCSZ202001007.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: